12 Information Technology Stocks Moving In Friday’s Pre-Market Session

 

 

Gainers

  • Taoping (NASDAQ:TAOP) shares rose 18.32% to $3.81 during Friday’s pre-market session. The market value of their outstanding shares is at $50.8 million.
  • One Stop Systems (NASDAQ:OSS) shares moved upwards by 11.82% to $5.92. The company’s market cap stands at $109.5 million.
  • Atlassian Corporation (NASDAQ:TEAM) stock rose 11.69% to $298.0. The market value of their outstanding shares is at $74.5 billion. The company’s, Q4 earnings came out yesterday.
  • Qumu (NASDAQ:QUMU) shares rose 8.64% to $2.64. The market value of their outstanding shares is at $46.4 million. The company’s, Q2 earnings came out yesterday.
  • Viant Technology (NASDAQ:DSP) stock increased by 7.63% to $17.2. The market value of their outstanding shares is at $1.0 billion.
  • KLA (NASDAQ:KLAC) shares increased by 5.18% to $336.0. The company’s market cap stands at $51.5 billion. As per the press release, Q4 earnings came out yesterday.

 

 

Losers

 

  • Plantronics (NYSE:POLY) stock decreased by 8.01% to $30.1 during Friday’s pre-market session. The company’s market cap stands at $1.2 billion. As per the news, the Q1 earnings report came out yesterday.
  • Support.com (NASDAQ:SPRT) stock declined by 7.03% to $7.28. The market value of their outstanding shares is at $176.3 million.
  • Aurora Mobile (NASDAQ:JG) stock decreased by 5.99% to $2.2. The market value of their outstanding shares is at $259.4 million.
  • Casa Systems (NASDAQ:CASA) shares fell 4.85% to $7.86. The market value of their outstanding shares is at $667.4 million. As per the news, the Q2 earnings report came out yesterday.
  • Sonim Technologies (NASDAQ:SONM) shares declined by 4.73% to $0.41. The market value of their outstanding shares is at $27.5 million.
  • Skyworks Solutions (NASDAQ:SWKS) stock decreased by 4.62% to $187.6. The company’s market cap stands at $30.9 billion. As per the press release, Q3 earnings came out yesterday.

 

 

Total
0
Shares
Related Posts
Read More

Inhibrx Shares Up ~20%; Co Earlier Says INBRX-101 Shows Favorable Safety Profile In Patients With Alpha-1 Antitrypsin Deficiency; Says Study Demonstrates Potential To Achieve Normal Alpha-1 Antitrypsin Levels With Monthly Dosing

- Inhibrx, Inc. (NASDAQ:INBX), a biotechnology company with four clinical programs in development and an emerging pre-clinical pipeline, today announced interim results from a Phase 1 clinical trial evaluating the safety

INBX